The Brooklyn College Cancer Center opened in Summer of 2020.
Dr. Patrick I. Borgen is the chairman of surgery at Maimonides Medical Center in Brooklyn, New York. He is also the founder and director of the Brooklyn Breast Cancer Program at Maimonides Cancer Center and clinical professor, Department of Surgery, SUNY Downstate University Hospital of Brooklyn.
Dr. Carol L. Brown is the senior vice president, chief health equity officer, and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center. She is the director of MSK’s Office of Diversity Programs in Clinical Care, Research, and Training.
Dr. Marilyn Fraser is the chief executive officer of the Arthur Ashe Institute for Urban Health, a community-based organization dedicated to addressing health inequities. Dr. Fraser is a research associate professor in both the Department of Medicine and the School of Public Health at SUNY Downstate Health Sciences University. She also serves as the co-director of the Brooklyn Health Disparities Center.
Bernard Garil ’62 is a longtime supporter of Brooklyn College. He has served on the board of the Brooklyn College Foundation since 1997, holding several positions over the years, including treasurer, chair of both the Audit and Investment committees, and chair of the 1999 Campaign for Students. He currently serves on the Leukemia & Lymphoma Society Education and Services Committee as well as on the Pediatric Oncology Visiting Committee at Dana-Farber Cancer Institute.
Professor Jason S. Lewis, Ph.D. is the Emily Tow Jackson Chair in Oncology, vice chair for Research of the Department of Radiology, and chief of the Radiochemistry and Imaging Sciences Service at Memorial Sloan Kettering Cancer Center.
Dr. Moro Salifu is chair of the Department of Medicine at SUNY Downstate, and the director of the NIH-funded Brooklyn Health Disparities Center. He is also chief of the Division of Nephrology, and director of the Kidney Transplant Program at Downstate.
Dr. Joanne Waldstreicher ’81 is the chief medical officer of Johnson & Johnson. She has oversight across the company’s pharmaceuticals, medical devices, and consumer products for safety, epidemiology, clinical, and regulatory operations cross-sector transformation, collaborations on ethical science, technology, and R&D policies—including clinical trial transparency and compassionate access. Dr. Waldstreicher also chairs the R&D Development Pharmaceutical Pipeline Review Committee. She is a Brooklyn College Foundation trustee and the recipient of the Brooklyn College 2021 Distinguished Alumna Award.